About
In addition to serving as chair of the organization and leader of Hodgson Russ s False Claims Act & Whistleblower Representation and Business Crimes, Regulatory Offenses & Corporate Investigations Practices, Dan is a member of the firm s Business Litigation Practice, placing Dan a number of the company s leaders in both civil business litigation and white-collar criminal and regulatory subjects, which includes corporate investigations and compliance. Dan has also seemed in numerous federal False Claims Act cases on behalf of both relators and defendants. He led a group of Hodgson Russ legal professionals in the successful illustration of two of the plaintiffs who blew the whistle on Johnson & Johnson for its off-label advertising of Risperdal, resulting in the largest-ever False Claims Act settlement. Dan additionally serves as the corporation s primary dating companion on key engagements regarding a main business financial institution, a massive regional creation and construction control organization, and a global production issue, among others. A former assistant U.S. attorney and special prosecutor, Dan has served as counsel in numerous business instances; highbrow assets instances, which includes patent disputes; and white-collar crook investigations concerning taxation, fraud, antitrust, and environmental crimes. Dan has a robust technical background, and he has dealt with numerous cases concerning state-of-the-art clinical and technical issues. With representation of one in all the most important health care structures in New York State, Dan has extensive revel in inside the evaluation and defense of civil and criminal health care fraud investigations. He is also an skilled Surrogate s Court litigator, having represented objectants in one of the biggest Surrogate s Court accept as true with-accounting verdicts in New York State. His practice is commonly before the U.S. district courts, and he has regarded in 15 federal district courts during the last six years. › ›
